Abines v. Duque III

A writ of continuing mandamus is a special remedy available only in connection with the enforcement or violation of an environmental law, rule, regulation, or right therein; it cannot be invoked to address alleged violations of the right to health. Furthermore, mandamus will not lie to compel government officials to perform acts that involve the exercise of discretion, judgment, or technical expertise, as such compulsion would violate the principle of separation of powers.

In 2016, the Department of Health (DOH) implemented a school-based dengue vaccination program using Dengvaxia, targeting elementary students nine years old and above in select regions. Following a 2017 advisory from the vaccine's manufacturer, Sanofi Pasteur, which indicated a risk of severe disease for vaccinated individuals without prior dengue infection, the DOH suspended the program. Petitioners, 74 children who received the vaccine, filed a direct petition for mandamus before the Supreme Court, alleging that respondents—various health and education officials—failed in their constitutional and statutory duty to protect the right to health. They sought a writ of continuing mandamus to compel the government to disseminate reports, conduct studies, create a registry of vaccinees, and provide free medical services and treatment.

• Nature of the Petition: Seventy-four children, represented by their parents, filed a Petition for Mandamus under Rule 65, seeking the issuance of a writ of continuing mandamus against several government officials. They alleged that the respondents failed to protect their right to health in connection with the DOH's Dengvaxia immunization program.
• The Dengvaxia Vaccination Program: In 2015-2016, the DOH, under then-Secretary Janette Garin, procured Dengvaxia and implemented a school-based vaccination program for children aged nine and above in the National Capital Region, Region III, and Region IV-A. The program was later expanded to include Cebu.
• Safety Concerns and Suspension: In November 2017, Sanofi Pasteur issued an advisory stating Dengvaxia was only beneficial to those with prior dengue infection and could cause severe disease in those without. Following this, then-DOH Secretary Francisco Duque III suspended the vaccination program on December 1, 2017. The Food and Drug Administration (FDA) also suspended the vaccine's sale, marketing, and distribution.
• Petitioners' Claims: Petitioners argued they were used as "guinea pigs" and sustained direct injury to their health and lives. They contended that respondents violated their constitutional and statutory duties to protect the right to health by haphazardly implementing the program without proper study and assessment.
• Respondents' Defense: Respondents argued the petition violated the doctrine of hierarchy of courts, that mandamus did not lie because the acts sought were discretionary, and that a writ of continuing mandamus was unavailable for non-environmental issues. They also claimed the reliefs sought had already been substantially satisfied through various administrative actions (e.g., creating a task force, disseminating information, providing free medical services, and monitoring vaccinees).

• Legal Standing: Petitioners asserted they had standing due to the direct and substantial injury to their health and lives from the Dengvaxia inoculation. Alternatively, they argued the Court should exercise liberality given the transcendental importance of the right to health.
• Doctrine of Hierarchy of Courts: Petitioners claimed their case fell under exceptions to the doctrine, citing issues of transcendental importance, a time element due to ongoing health issues, lack of other adequate remedy, and questions of public welfare and policy.
• Violation of Right to Health: Petitioners argued that respondents failed in their duty to protect the right to health, as mandated by the Constitution (Articles II, XIII, XV), Presidential Decree No. 603, and international conventions. They cited the DOH's and FDA's mandates under the Administrative Code and Republic Act No. 9711.
• Entitlement to Writ of Continuing Mandamus: Petitioners contended that the importance and urgency of the relief warranted the issuance of a writ of continuing mandamus, even though it is typically an environmental remedy, citing Metropolitan Manila Development Authority v. Concerned Residents of Manila Bay.

• Violation of Hierarchy of Courts: Respondents argued the petition should have been filed first with the Regional Trial Court, as the issues were not purely legal and required factual determination.
• Non-Availability of Mandamus: Respondents maintained that mandamus, particularly continuing mandamus, does not lie because the acts sought (e.g., conducting studies, creating registries, providing specific medical services) are not ministerial duties enjoined by law but involve the exercise of discretion and technical expertise.
• Separation of Powers: Respondents contended that granting the reliefs would violate the separation of powers by allowing the judiciary to supervise and dictate the execution of health policies, which is an executive function.
• Mootness: Respondents asserted the petition was moot because they had already performed the acts sought, such as disseminating information, submitting reports to Congress, studying the vaccine, creating a master list of vaccinees (subject to privacy laws), and providing free medical monitoring and services.

• Hierarchy of Courts: Whether the petition is exempt from the doctrine of hierarchy of courts, allowing direct filing with the Supreme Court.
• Availability of Continuing Mandamus: Whether a writ of continuing mandamus may be issued for a controversy not involving the enforcement or violation of an environmental law or right.
• Propriety of Mandamus Relief: Whether mandamus lies to compel the performance of the specific acts prayed for by the petitioners.
• Separation of Powers: Whether granting the petition would violate the principle of separation of powers.

• Hierarchy of Courts: The petition violated the doctrine of hierarchy of courts. Resolving the issues required the evaluation of factual matters and evidence, which should first be threshed out in lower courts. The cited exceptions (transcendental importance, time element, etc.) did not overcome this requirement because the petition did not present purely legal questions.
• Availability of Continuing Mandamus: The writ of continuing mandamus is unavailable. The Rules of Procedure for Environmental Cases explicitly limit its application to cases involving an "environmental law, rule or regulation or a right therein." The petition primarily invoked the right to health, not an ecological or environmental right.
• Propriety of Mandamus Relief: Even treated as a regular petition for mandamus under Rule 65, it must fail. The specific acts sought (e.g., public dissemination of reports, creation of a registry, provision of free medical services) are not ministerial duties specifically enjoined by law. They involve discretionary functions and the exercise of technical expertise by the DOH and FDA. Furthermore, the petition lacked a sufficient scientific and empirical basis to demonstrate a grave error or systematic failure by the respondents.
• Separation of Powers: Granting the reliefs would violate the separation of powers. The judiciary cannot arrogate upon itself the power to oversee and direct the execution of health policies, which are within the executive's sphere of competence. The Court cannot substitute its judgment for that of administrative agencies possessing specialized knowledge.

• Writ of Continuing Mandamus — A special remedy available only in environmental cases, directing a government agency or officer to perform an act or series of acts decreed by final judgment until full satisfaction. It requires a clear legal duty arising from an environmental law, rule, regulation, or right. The petitioner must allege: (a) serious and systematic inability to meet environmental obligations despite demands; (b) convincing circumstances of irreparable ecological damage; and (c) specific, measurable, attainable, realistic, and timebound (SMART) objectives to avoid that damage.
• Separation of Powers — The constitutional principle dividing governmental power among the Legislative, Executive, and Judicial branches, each supreme within its own sphere. It prevents the concentration of power and mandates mutual respect among co-equal branches. The judiciary will not interfere with the discretionary or technical functions of the executive unless there is a clear showing of grave abuse of discretion amounting to lack or excess of jurisdiction.
• Doctrine of Hierarchy of Courts — A policy requiring parties to seek recourse first from lower courts with concurrent jurisdiction, allowing the Supreme Court to function as a court of last resort. Direct invocation of the Supreme Court's original jurisdiction is allowed only for exceptional reasons, clearly and specifically pleaded, and only when the questions presented are purely legal.

• "A petition for continuing mandamus may be filed when a government agency, instrumentality, or officer unlawfully neglects the performance of an act in connection with the enforcement or violation of the environmental law, regulation, or right, or excludes another person from the use or enjoyment of that right. It 'should mainly involve an environmental and other related law, rule, regulation, or a right therein.'" — This passage defines the exclusive scope of the writ of continuing mandamus.
• "The principle [of separation of powers] presupposes mutual respect by and [among the three branches] and calls for them to be left alone to discharge their duties as they see fit." — This underscores the foundational respect among co-equal branches that limits judicial intervention.
• "Mandamus lies to compel the performance of duties that are purely ministerial in nature, not those that are discretionary, and the official can only be directed by mandamus to act but not to act one way or the other." — This articulates the fundamental limitation on the writ of mandamus.

• Metropolitan Manila Development Authority v. Concerned Residents of Manila Bay, 595 Phil. 305 (2008) — Introduced the concept of continuing mandamus in Philippine jurisprudence, ordering government agencies to clean up Manila Bay and submit progress reports. The Court distinguished the present case, noting that MMDA involved environmental protection, whereas this case concerns health.
• Dolot v. Paje, 716 Phil. 458 (2013) — Defined the sufficiency of substance required for a petition for continuing mandamus, including the need to allege a specific legal duty connected to an environmental law. Applied to show the petition's insufficiency.
• Knights of Rizal v. DMCI Homes, Inc., 809 Phil. 453 (2017) — Reiterated that mandamus does not lie to control discretionary executive functions and that courts cannot substitute their judgment for that of officials in a better position to consider matters. Cited to support the non-interference with executive discretion.
• Gios-Samar, Inc. v. Department of Transportation and Communications, G.R. No. 217158, March 12, 2019 — Enumerated the exceptions to the doctrine of hierarchy of courts but emphasized that even for transcendental importance, the questions must be purely legal. Used to dismiss the petitioners' claimed exceptions.

• Rule 8, Sections 1 and 2, Rules of Procedure for Environmental Cases — Provides the procedure and jurisdictional requirements for petitions for continuing mandamus, explicitly limiting it to environmental matters. The Court applied these provisions to dismiss the petition for being outside the writ's scope.
• Rule 65, Rules of Court — Governs the special civil action for mandamus. The Court analyzed the petition under this rule as an alternative but found it unavailing because the respondents' duties were not ministerial.
• Article II, Sections 15 and 16; Article XIII, Sections 11 and 12; Article XV, Section 3(2), 1987 Constitution — Cited by petitioners as the source of the State's duty to protect the right to health. The Court acknowledged these provisions but held they do not enjoin the specific ministerial acts prayed for.
• Republic Act No. 9711 (Food and Drug Administration Act of 2009) — Outlines the FDA's functions, including the regulation and monitoring of health products. The Court noted the FDA's actions were based on its technical mandate, which the judiciary cannot supplant.

Caguioa, Hernando, Lazaro-Javier, Inting, Zalameda, Gaerlan, Rosario, J. Lopez, Dimaampao, Marquez, and Kho, Jr., JJ., concur. Gesmundo, C.J. and M. Lopez, J., on official business. Singh, J., see my separate opinion.

• Justice Alfredo Benjamin S. Caguioa — While concurring in the result, Justice Caguioa's separate opinion (not detailed in the provided text) may have offered additional or nuanced reasoning on the limits of mandamus or the Court's role in public health crises.